Materials and methods
Data source and patient selection
Statistical analysis
Results
Baseline characteristics
Total N = 8056 | N = 967 | N0 N = 7089 | P | |
---|---|---|---|---|
Tumor size (cm) | 0.015 | |||
< 1 | 1442 (17.9) | 169 (17.48) | 1273 (17.96) | |
1–1.9 | 1736 (21.55) | 231 (23.89) | 1505 (21.23) | |
2–2.9 | 1160 (14.4) | 137 (14.17) | 1023 (14.43) | |
3+ | 1482 (18.4) | 200 (20.68) | 1282 (18.08) | |
Not stated | 2236 (27.76) | 230 (23.78) | 2006 (28.3) | |
Histology | < 0.001 | |||
Adenocarcinoma | 7835 (97.26) | 920 (95.14) | 6915 (97.55) | |
Mucinous carcinoma | 221 (2.74) | 47 (4.86) | 174 (2.45) | |
CEA* | < 0.001 | |||
Positive | 457 (5.67) | 75 (7.76) | 382 (5.39) | |
Negative | 3123 (38.77) | 439 (45.4) | 2684 (37.86) | |
Borderline/unknown | 4476 (55.56) | 453 (46.85) | 4023 (56.75) | |
Grade | < 0.001 | |||
Well-differentiated | 1605 (19.92) | 116 (12.0) | 1489 (21) | |
Moderately differentiated | 5054 (62.74) | 625 (64.63) | 4429 (62.48) | |
Poorly differentiated | 563 (6.99) | 162 (16.75) | 401 (5.66) | |
Undifferentiated | 55 (0.68) | 10 (1.03) | 45 (0.63) | |
Unknown | 779 (9.67) | 54 (5.58) | 725 (10.23) | |
Year | 0.112 | |||
2004–2006 | 1680 (20.85) | 216 (22.34) | 1464 (20.65) | |
2007–2009 | 2998 (37.21) | 331 (34.23) | 2667 (37.62) | |
2010–2012 | 3378 (41.93) | 420 (43.43) | 2958 (41.73) | |
Age (years) | < 0.001 | |||
Up to 49 | 731 (9.07) | 114 (11.79) | 617 (8.7) | |
50–64 | 3101 (38.49) | 455 (47.05) | 2646 (37.33) | |
65–79 | 3162 (39.25) | 324 (33.51) | 2838 (40.03) | |
80+ | 1062 (13.18) | 74 (7.65) | 988 (13.94) | |
Gender | 0.257 | |||
Male | 3924 (48.71) | 454 (46.95) | 3470 (48.95) | |
Female | 4132 (51.29) | 513 (53.05) | 3619 (51.05) | |
Race | 0.321 | |||
Black | 988 (12.26) | 117 (12.1) | 871 (12.29) | |
White | 6371 (79.08) | 753 (77.87) | 5618 (79.25) | |
Others | 647 (8.03) | 88 (9.1) | 559 (7.89) | |
Unknown | 50 (0.62) | 9 (0.93) | 41 (0.58) | |
Marital status | 0.007 | |||
Married | 4865 (60.39) | 626 (64.74) | 4239 (59.8) | |
Single/widowed | 2042 (25.35) | 228 (23.58) | 1814 (25.59) | |
Other/unknown | 1149 (14.26) | 113 (11.69) | 1036 (14.61) | |
Primary site | < 0.001 | |||
Cecum | 1781 (22.11) | 204 (21.1) | 1577 (22.25) | |
Ascending colon | 1989 (24.69) | 181 (18.72) | 1808 (25.5) | |
Hepatic flexure | 399 (4.95) | 42 (4.34) | 357 (5.04) | |
Transverse colon | 615 (7.63) | 61 (6.31) | 554 (7.81) | |
Splenic flexure | 157 (1.95) | 13 (1.34) | 144 (2.03) | |
Descending colon | 410 (5.09) | 49 (5.07) | 361 (5.09) | |
Sigmoid colon | 2705 (33.58) | 417 (43.12) | 2288 (32.28) | |
Total lymph nodes Median (IQR*) | 17 (14–22) | 17 (14–22) | 17 (14–22) | 0.375 |
Radiation | < 0.001 | |||
None | 8043 (99.84) | 959 (99.17) | 7084 (99.93) | |
Postoperative | 13 (0.16) | 8 (0.83) | 5 (0.07) | |
Cause of death | < 0.001 | |||
Alive | 6650 (82.55) | 786 (81.28) | 5864 (82.72) | |
Dead from cancer | 322 (4.00) | 91 (9.41) | 231 (3.26) | |
Dead not from cancer | 1084 (13.46) | 90 (9.31) | 994 (14.02) | |
Follow-up time (months) | 68 (47–94) | 66 (45–94) | 66 (45–94) | 0.176 |
Risk factors of lymph node metastasis
Unadjusted logistic regression | Adjusted logistic regression | Adjusted selection from adjusted logistic regression | ||||
---|---|---|---|---|---|---|
OR* (95% CI*) | P | OR (95% CI) | P | OR (95% CI) | P | |
Tumor size (cm) | ||||||
< 1 | Reference | |||||
1–1.9 | 1.16 (0.94–1.43) | 0.180 | ||||
2–2.9 | 1.01 (0.79–1.28) | 0.943 | ||||
3+ | 1.18 (0.94–1.46) | 0.149 | ||||
Not stated | 0.86 (0.70–1.07) | 0.173 | ||||
Histology | ||||||
Adenocarcinoma | Reference | Reference | Reference | |||
Mucinous carcinoma | 2.03 (1.45–2.80) | < 0.001 | 2.26 (1.61–3.21) | < 0.001 | 2.30 (1.61–3.21) | < 0.001 |
CEA* | ||||||
Positive | Reference | Reference | Reference | |||
Negative | 0.83 (0.64–1.10) | 0.181 | 0.76 (0.58–0.99) | 0.047 | 0.76 (0.58–1.00) | 0.047 |
Borderline/unknown | 0.57 (0.44–0.75) | < 0.001 | 0.56 (0.43–0.74) | < 0.001 | 0.56 (0.43–0.74) | < 0.001 |
Grade | ||||||
Well-differentiated | Reference | Reference | Reference | |||
Moderately differentiated | 1.81 (1.48–2.24) | < 0.001 | 1.74 (1.42–2.15) | < 0.001 | 1.74 (1.42–2.15) | < 0.001 |
Poorly differentiated | 5.19 (3.99–6.75) | < 0.001 | 5.16 (3.96–6.75) | < 0.001 | 5.16 (3.96–6.75) | < 0.001 |
Undifferentiated | 2.85 (1.33–5.58) | 0.004 | 3.01 (1.39–5.97) | 0.003 | 3.01 (1.39–5.97) | 0.003 |
Unknown | 0.96 (0.68–1.33) | 0.793 | 0.56 (0.64–1.26) | 0.571 | 0.91 (0.64–1.26) | 0.571 |
Year | ||||||
2004–2006 | Reference | |||||
2007–2009 | 0.84 (0.70–1.01) | 0.064 | ||||
2010–2012 | 0.96 (0.81–1.15) | 0.669 | ||||
Age (years) | ||||||
Up to 49 | Reference | Reference | Reference | |||
50–64 | 0.93 (0.75–1.17) | 0.528 | 0.99 (0.79–1.26) | 0.970 | 0.99 (0.79–1.26) | 0.970 |
65–79 | 0.62 (0.49–0.78) | < 0.001 | 0.66 (0.52–0.84) | < 0.001 | 0.66 (0.52–0.84) | < 0.001 |
80+ | 0.41 (0.30–0.55) | < 0.001 | 0.44 (0.32–0.60) | < 0.001 | 0.44 (0.32–0.60) | < 0.001 |
Gender | ||||||
Male | Reference | |||||
Female | 1.08 (0.95–1.24) | 0.243 | ||||
Race | ||||||
Black | Reference | |||||
White | 0.99 (0.81–1.23) | 0.983 | ||||
Others | 1.17 (0.87–1.57) | 0.294 | ||||
Marital status | ||||||
Married | Reference | Reference | Reference | |||
Single/widowed | 0.85 (0.72–0.99) | 0.050 | 0.98 (0.82–1.15) | 0.781 | 0.98 (0.82–1.15) | 0.781 |
Other/unknown | 0.74 (0.60–0.91) | 0.005 | 0.73 (0.59–0.91) | 0.005 | 0.73 (0.59–0.91) | 0.005 |
Primary site | ||||||
Cecum | Reference | Reference | Reference | |||
Ascending colon | 0.77 (0.63–0.96) | 0.017 | 0.77 (0.62–0.96) | 0.018 | 0.77 (0.62–0.96) | 0.018 |
Hepatic flexure | 0.91 (0.63–1.28) | 0.597 | 0.91 (0.63–1.29) | 0.592 | 0.91 (0.63–1.29) | 0.592 |
Transverse colon | 0.85 (0.62–1.14) | 0.296 | 0.81 (0.59–1.10) | 0.184 | 0.81 (0.59–1.10) | 0.184 |
Splenic flexure | 0.70 (0.37–1.21) | 0.229 | 0.63 (0.33–1.11) | 0.134 | 0.63 (0.33–1.11) | 0.134 |
Descending colon | 1.05 (0.75–1.45) | 0.777 | 0.92 (0.64–1.28) | 0.612 | 0.92 (0.64–1.28) | 0.612 |
Sigmoid colon | 1.41 (1.18–1.69) | < 0.001 | 1.26 (1.05–1.53) | 0.014 | 1.26 (1.05–1.53) | 0.014 |
Lymph node metastasis and patient survival
Unadjusted | Adjusted | Variable selection | ||||
---|---|---|---|---|---|---|
HR* (95% CI*) | P | HR (95% CI) | P | HR (95% CI) | P | |
N stage | ||||||
N0 | Reference | |||||
N1/N2 | 1.11 (0.95–1.29) | 0.21 | ||||
Tumor size (cm) | ||||||
< 1 | Reference | Reference | Reference | |||
1–1.9 | 1.16 (0.98–1.39) | 0.091 | 1.08 (0.91–1.29) | 0.405 | 1.09 (0.91–1.30) | 0.348 |
2–2.9 | 1.41 (1.17–1.69) | < 0.001 | 1.21 (1.01–1.46) | 0.043 | 1.23 (1.02–1.48) | 0.029 |
3+ | 1.45 (1.22–1.73) | < 0.001 | 1.29 (1.08–1.53) | 0.005 | 1.30 (1.09–1.54) | 0.004 |
Not stated | 0.86 (0.72–1.02) | 0.086 | 0.93 (0.78–1.11) | 0.433 | 0.93 (0.78–1.11) | 0.448 |
Histology | ||||||
Adenocarcinoma | Reference | Reference | ||||
Mucinous carcinoma | 1.47 (1.14–1.91) | 0.003 | 1.12 (0.86–1.46) | 0.391 | ||
CEA* | ||||||
Positive | Reference | Reference | Reference | |||
Negative | 0.40 (0.33–0.48) | < 0.001 | 0.50 (0.41–0.60) | < 0.001 | 0.49 (0.41–0.60) | < 0.001 |
Borderline/unknown | 0.51 (0.43–0.61) | < 0.001 | 0.61 (0.51–0.73) | < 0.001 | 0.61 (0.51–0.72) | < 0.001 |
Grade | ||||||
Well-differentiated | Reference | Reference | ||||
Moderately differentiated | 1.04 (0.91–1.19) | 0.600 | 1.05 (0.91–1.20) | 0.502 | ||
Poorly differentiated | 1.10 (0.88–1.37) | 0.422 | 1.12 (0.89–1.40) | 0.340 | ||
Undifferentiated | 2.31 (1.43–3.72) | < 0.001 | 2.02 (1.25–3.26) | 0.004 | ||
Unknown | 0.90 (0.73–1.11) | 0.320 | 1.05 (0.85–1.30) | 0.666 | ||
Year | ||||||
2004–2006 | Reference | |||||
2007–2009 | 1.02 (0.90–1.16) | 0.745 | ||||
2010–2012 | 0.86 (0.74–1.01) | 0.063 | ||||
Age (years) | ||||||
Up to 49 | Reference | Reference | Reference | |||
50–64 | 1.84 (1.25–2.71) | 0.002 | 1.92 (1.30–2.82) | 0.001 | 1.91 (1.30–2.82) | 0.001 |
65–79 | 5.39 (3.72–7.82) | < 0.001 | 5.33 (3.67–7.76) | < 0.001 | 5.37 (3.70–7.80) | < 0.001 |
80+ | 17.44 (12.00–25.36) | < 0.001 | 15.68 (10.72–22.91) | < 0.001 | 15.82 (10.86–23.04) | < 0.001 |
Gender | ||||||
Male | Reference | |||||
Female | 0.99 (0.89–1.10) | 0.827 | ||||
Race | ||||||
Black | Reference | Reference | Reference | |||
White | 1.00 (0.85–1.17) | 0.954 | 0.78 (0.67–0.92) | 0.004 | 0.78 (0.66–0.92) | 0.003 |
Others | 0.56 (0.42–0.74) | < 0.001 | 0.50 (0.38–0.66) | < 0.001 | 0.50 (0.38–0.66) | < 0.001 |
Marital status | ||||||
Married | Reference | Reference | Reference | |||
Single/widowed | 2.10 (1.88–2.35) | < 0.001 | 1.38 (1.23–1.55) | < 0.001 | 1.38 (1.23–1.55) | < 0.001 |
Other/unknown | 1.05 (0.89–1.25) | 0.562 | 1.02 (0.86–1.21) | 0.823 | 1.02 (0.86–1.21) | 0.839 |
Primary site | ||||||
Cecum | Reference | Reference | ||||
Ascending colon | 0.99 (0.86–1.13) | 0.866 | 1.07 (0.93–1.23) | 0.369 | ||
Hepatic flexure | 0.87 (0.68–1.11) | 0.264 | 0.95 (0.73–1.21) | 0.658 | ||
Transverse colon | 0.73 (0.58–0.91) | 0.006 | 0.91 (0.73–1.14) | 0.405 | ||
Splenic flexure | 0.72 (0.48–1.07) | 0.106 | 1.05 (0.70–1.58) | 0.803 | ||
Descending colon | 0.64 (0.49–0.85) | 0.002 | 0.96 (0.73–1.28) | 0.802 | ||
Sigmoid colon | 0.58 (0.50–0.67) | < 0.001 | 1.01 (0.87–1.17) | 0.883 |
Unadjusted | Adjusted | Variable selection | ||||
---|---|---|---|---|---|---|
HR* (95% CI*) | P | HR (95% CI) | P | HR (95% CI) | P | |
N stage | ||||||
N0 | Reference | Reference | Reference | |||
N1/N2 | 2.95 (2.31–3.76) | < 0.001 | 3.02 (2.34–3.89) | < 0.001 | 3.00 (2.33–3.87) | < 0.001 |
Tumor size (cm) | ||||||
< 1 | Reference | Reference | Reference | |||
1–1.9 | 1.22 (0.84–1.79) | 0.296 | 1.09 (0.74–1.60) | 0.661 | 1.09 (0.74–1.60) | 0.649 |
2–2.9 | 1.44 (0.97–2.15) | 0.073 | 1.21 (0.81–1.80) | 0.364 | 1.21 (0.81–1.80) | 0.341 |
3+ | 1.90 (1.33–2.73) | < 0.001 | 1.57 (1.09–2.26) | 0.015 | 1.57 (1.09–2.26) | 0.014 |
Not stated | 0.88 (0.60–1.29) | 0.504 | 0.93 (0.63–1.37) | 0.702 | 0.93 (0.63–1.37) | 0.709 |
Histology | ||||||
Adenocarcinoma | Reference | Reference | Reference | |||
Mucinous carcinoma | 2.11 (1.33–3.36) | 0.002 | 1.45 (0.90–2.33) | 0.124 | 1.45 (0.90–2.33) | 0.114 |
CEA* | ||||||
Positive | Reference | Reference | Reference | |||
Negative | 0.33 (0.23–0.47) | < 0.001 | 0.40 (0.28–0.58) | < 0.001 | 0.40 (0.28–0.58) | < 0.001 |
Borderline/unknown | 0.35 (0.25–0.50) | < 0.001 | 0.45 (0.32–0.63) | < 0.001 | 0.45 (0.32–0.64) | < 0.001 |
Grade | ||||||
Well-differentiated | Reference | Reference | Reference | |||
Moderately differentiated | 1.06 (0.79–1.42) | 0.697 | 1.03 (0.77–1.38) | 0.834 | 1.02 (0.76–1.37) | 0.874 |
Poorly differentiated | 1.92 (1.29–2.87) | 0.001 | 1.49 (0.99–2.24) | 0.057 | 1.48 (0.98–2.23) | 0.060 |
Undifferentiated | 3.43 (1.48–7.93) | 0.004 | 3.03 (1.30–7.05) | 0.010 | 2.99 (1.29–6.96) | 0.011 |
Unknown | 0.77 (0.48–1.24) | 0.285 | 0.88 (0.54–1.44) | 0.604 | 0.88 (0.54–1.43) | 0.599 |
Year | ||||||
2004–2006 | Reference | Reference | Reference | |||
2007–2009 | 0.86 (0.66–1.12) | 0.274 | 0.91 (0.69–1.19) | 0.474 | 0.91 (0.70–1.19) | 0.488 |
2010–2012 | 0.63 (0.46–0.87) | 0.004 | 0.67 (0.49–0.92) | 0.014 | 0.68 (0.50–0.93) | 0.016 |
Age (years) | ||||||
Up to 49 | Reference | Reference | Reference | |||
50–64 | 0.96 (0.59–1.54) | 0.855 | 1.07 (0.66–1.74) | 0.778 | 1.07 (0.66–1.74) | 0.774 |
65–79 | 1.58 (0.99–2.50) | 0.052 | 1.63 (1.02–2.60) | 0.040 | 1.65 (1.04–2.62) | 0.033 |
80+ | 3.53 (2.19–5.70) | < 0.001 | 3.33 (2.03–5.45) | < 0.001 | 3.37 (2.08–5.47) | < 0.001 |
Gender | ||||||
Male | Reference | |||||
Female | 0.96 (0.77–1.19) | 0.694 | ||||
Race | ||||||
Black | Reference | |||||
White | 1.00 (0.85–1.17) | 0.954 | ||||
Others | 0.56 (0.42–0.74) | < 0.001 | ||||
Marital status | ||||||
Married | Reference | Reference | Reference | |||
Single/widowed | 2.00 (1.58–2.53) | < 0.001 | 1.62 (1.27–2.06) | < 0.001 | 1.62 (1.27–2.06) | < 0.001 |
Other/unknown | 1.02 (0.72–1.46) | 0.905 | 1.01 (0.70–1.44) | 0.971 | 1.01 (0.70–1.44) | 0.967 |
Primary site | ||||||
Cecum | Reference | Reference | ||||
Ascending colon | 1.02 (0.76–1.37) | 0.897 | 1.19 (0.88–1.60) | 0.263 | ||
Hepatic flexure | 0.82 (0.48–1.41) | 0.479 | 0.91 (0.53–1.56) | 0.725 | ||
Transverse colon | 0.77 (0.48–1.24) | 0.284 | 1.01 (0.63–1.62) | 0.982 | ||
Splenic flexure | 0.13 (0.02–0.96) | 0.045 | 0.20 (0.03–1.42) | 0.107 | ||
Descending colon | 0.73 (0.41–1.29) | 0.280 | 1.03 (0.58–1.83) | 0.916 | ||
Sigmoid colon | 0.73 (0.54–0.98) | 0.038 | 1.04 (0.76–1.42) | 0.810 |
Competing risk analysis
SHR* (95% CI*) | P | |
---|---|---|
N stage | ||
N0 | Reference | |
N1/N2 | 2.96 (2.30–3.82) | < 0.001 |
Tumor size (cm) | ||
< 1 | Reference | |
1–1.9 | 1.09 (0.75–1.59) | 0.670 |
2–2.9 | 1.17 (0.78–1.74) | 0.461 |
3+ | 1.50 (1.03–2.19) | 0.026 |
Not stated | 0.93 (0.63–1.37) | 0.720 |
Histology | ||
Adenocarcinoma | Reference | |
Mucinous carcinoma | 1.46 (0.91–2.36) | 0.130 |
CEA* | ||
Positive | Reference | |
Negative | 0.45 (0.31–0.64) | < 0.001 |
Borderline/unknown | 0.48 (0.34–0.68) | < 0.001 |
Grade | ||
Well-differentiated | Reference | |
Moderately differentiated | 1.08 (0.80–1.45) | 0.730 |
Poorly differentiated | 1.60 (1.06–2.42) | 0.031 |
Undifferentiated | 2.91 (1.19–7.15) | 0.022 |
Unknown | 0.90 (0.55–1.49) | 0.601 |
Year | ||
2004–2006 | Reference | |
2007–2009 | 0.84 (0.65–1.10) | 0.180 |
2010–2012 | 0.60 (0.44–0.82) | 0.001 |
Age (years) | ||
Up to 49 | Reference | |
50–64 | 1.06 (0.65–1.72) | 0.841 |
65–79 | 1.61 (1.00–2.58) | 0.048 |
80+ | 3.01 (1.82–4.98) | <0.001 |
Race | ||
Black | Reference | |
White | 0.57 (0.43–0.76) | < 0.001 |
Others | 0.48 (0.28–0.81) | 0.007 |
Marital status | ||
Married | Reference | |
Single/widowed | 1.45 (1.13–1.87) | 0.003 |
Other/unknown | 0.96 (0.67–1.38) | 0.860 |
Primary site | ||
Cecum | Reference | |
Ascending colon | 1.21 (0.89–1.65) | 0.230 |
Hepatic flexure | 0.96 (0.56–1.65) | 0.881 |
Transverse colon | 1.05 (0.66–1.69) | 0.832 |
Splenic flexure | 0.20 (0.03–1.39) | 0.102 |
Descending colon | 1.09 (0.61–1.92) | 0.781 |
Sigmoid colon | 1.12 (0.81–1.55) | 0.490 |